These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14635469)

  • 21. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV; Cruz-Rivera M; Walton-Bowen K
    Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
    Maneechotesuwan K; Suthamsmai T; Ratanasaenglert K; Pipopsuthipaiboon S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S66-71. PubMed ID: 21728272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
    Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.
    Simpson AJ; Tufvesson E; Anderson SD; Romer LM; Bjermer L; Kippelen P
    J Appl Physiol (1985); 2013 Nov; 115(10):1450-6. PubMed ID: 24030662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bronchodilator response from increasing doses of terbutaline inhaled from a multi-dose powder inhaler (Turbuhaler).
    Persson G; Wirén JE
    Eur Respir J; 1990 Jan; 3(1):24-6. PubMed ID: 2311726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dose-response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children.
    Blackhall MI; O'Donnell SR
    Eur J Respir Dis; 1987 Aug; 71(2):96-101. PubMed ID: 3622669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
    Kaae R; Agertoft L; Pedersen S; Nordvall SL; Pedroletti C; Bengtsson T; Johannes-Hellberg I; Rosenborg J
    Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.
    Petersen AH; Korsatko S; Köhler G; Wutte A; Olschewski H; Sparre T; Råstam J; Wollmer P; Pieber TR
    Br J Clin Pharmacol; 2010 Mar; 69(3):271-8. PubMed ID: 20233198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled terbutaline administered via a spacer fully prevents exercise-induced asthma in young asthmatic subjects: a double-blind, randomized, placebo-controlled study.
    Dinh Xuan AT; Lebeau C; Roche R; Ferriere A; Chaussain M
    J Int Med Res; 1989; 17(6):506-13. PubMed ID: 2697625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of terbutaline and salbutamol inhalation in children with mild or moderate acute exacerbation of asthma.
    Chandra P; Paliwal L; Lodha R; Kabra SK
    Indian J Pediatr; 2004 Nov; 71(11):961-3. PubMed ID: 15572812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a new multidose powder inhaler with a pressurized aerosol in children with asthma.
    Fuglsang G; Pedersen S
    Pediatr Pulmonol; 1989; 7(2):112-5. PubMed ID: 2797920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identical efficacy of terbutaline multidose dry powder inhaler prior to and after 4 weeks of use by asthmatic patients.
    Stallaert RA
    Eur J Clin Pharmacol; 1995; 47(5):407-9. PubMed ID: 7720761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.
    van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
    Pulm Pharmacol Ther; 2008; 21(1):73-8. PubMed ID: 17292646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.